Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 269-084-6 | CAS number: 68187-29-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 50
- Absorption rate - dermal (%):
- 10
- Absorption rate - inhalation (%):
- 100
Additional information
Introduction
L-Glutamic acid, N-coco acyl derivative, compounds with triethanolamine (1:1) [EC Number: 269-084-6, CAS Number: 68187-29-1] is a UVCB substance. Physico-chemical properties of L-Glutamic acid, N-coco acyl derivative, compounds with triethanolamine (1:1), together with QSAR assessments and the results of in vitro and in vivo studies that were conducted either with the substance or with related, read-across substances have been used to determine, as far as possible, a toxicokinetic profile for L-Glutamic acid, N-coco acyl derivative, compounds with triethanolamine (1:1).
Physicochemical properties
L-Glutamic acid, N-coco acyl derivative, compounds with triethanolamine (1:1) is a UVCB. It is a white to pale yellow solid (a “sticky paste”) at room temperature with a melting point in the region of 131-134°C. Its relative density and vapour pressure at 20°C are 0.97 and 0.012 Pa, respectively. The partition coefficient (log Kow/Pow, 25°C) for each constituent ranged from -3.5809 to 0.3479 and for chemical safety assessment a weighted average log Pow of -1.58 was assigned. It is soluble in water at 383 mg/mL at 20°C.
Absorption
Oral absorption
The oral LD50of L-Glutamic acid, N-coco acyl derivative, compounds with triethanolamine (1:1) is reported to be 6500 mg/kg bw, with mortality observed at dose levels of 4.8 -14.3 g/kg (100% mortality at 8.3 g/kg and above). The study is of limited reliability and provides no further information for determining oral absorption. Data from an acute oral toxicity study on TEA Lauroyl L-Glutamate Solution (LT-12), a related substance that has been proposed for read-across purposes, indicates an LD50of >5000 mg/kg bw but < 10,000 mg/kg bw and at lethal dose levels clinical signs included cyanosis, opisthotonus and convulsions.
The available in vivo data, indicate that oral absorption of the read across substance TEA Lauroyl L-Glutamate Solution (LT-12) does occur and therefore absorption of L-Glutamic acid, N-coco acyl derivative, compounds with triethanolamine (1:1) is also expected. L-Glutamic acid, N-coco acyl derivative, compounds with triethanolamine (1:1) is water soluble and would be expected to dissolve readily in gastrointestinal fluid. Furthermore, it has a moderate log Pow (average log Pow -1.58), which would favour absorption by passive diffusion. The substance is a UVCB and with the data available, it is not possible to determine if all components would be absorbed to the same degree. Therefore, in the absence of any other information and for the purposes of human DNEL setting, 50% oral absorption is assumed for human health risk assessment purposes.
Dermal absorption
No data are available regarding the dermal absorption of L-Glutamic acid, N-coco acyl derivative, compounds with triethanolamine (1:1). Although the substance was concluded to be non-corrosive and non-irritating to skin inin vitrostudies using a 3D skin model, both studies showed a reduction in keratinocyte viability compared to controls, suggesting some penetration of the dermal layer had occurred. In addition, a 5% solution of L-Glutamic acid, N-coco acyl derivative, compounds with triethanolamine (1:1) was concluded to be slightly irritating in an in vivo skin irritation study in rabbits; skin irritation is known to enhance penetration.
The available data, indicate that some degree of dermal absorption of L-Glutamic acid, N-coco acyl derivative, compounds with triethanolamine (1:1) may occur. This is supported by its high water solubility and the moderate lipophilic nature of at least some of its constituents. However, several components have log Pow values below -1, which would limit their potential to cross the stratum corneum. Therefore, in the absence of any other information and for the purposes of human DNEL setting, 10% dermal absorption (based on the ECHA guidance) is assumed for human health risk assessment purposes.
Inhalation absorption
No data are available on acute inhalation toxicity of either the substance or any read across substance.
L-Glutamic acid, N-coco acyl derivative, compounds with triethanolamine (1:1) iswater soluble with a moderate log P value (for at least some of the constituents); this would favour absorptiondirectly across the respiratory tract epithelium by passive diffusion.Therefore, in the absence of any other information and for the purposes of human DNEL setting, 100% inhalation absorption is assumed for human health risk assessment purposes.
Distribution, Metabolism and Elimination
No in vivo information is available to describe the distribution, metabolism or elimination ofL-Glutamic acid, N-coco acyl derivative, compounds with triethanolamine (1:1). However, given its organic nature, it is expected that once absorbed the components of the substance will be widely distributed within the body and metabolised to substrates of endogenous metabolism or excreted mainly unchanged (triethanolamine). The acyl residues will be distributed via chylomicrons, while glutamic acid will reach the liver, and there subjected to metabolism or re-used for other metabolic processes.
The acyl residues and glutamate will be used as a source of energy within the citric acid cycle; in case of glutamate, it will be also used for the synthesis of peptides or other amino acids, or excreted in the form of urea.
Most of the components deriving from metabolism/degradation of the parent compound will be re-used for other metabolic processes within the body and eventually excreted in the urine. Based on ADME data in rats, most of the released triethanolamine is expected to be excreted unchanged, with only a minor part (<3%) as glucuronide conjugates. Excretion will be via both urine and faeces.
Bioaccumulation is considered unlikely to occur.
Conclusions
Based on in vitro and in vivo data from studies performed with L-Glutamic acid, N-coco acyl derivative, compounds with triethanolamine (1:1), oral absorption is estimated at 50%, inhalation absorption is estimated at 100% and dermal absorption is estimated at 10%.
There is no potential for bioaccumulation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.